Plexus Approves $30M Share Repurchase Program

Reading time ( words)

Plexus Corp.'s Board of Directors has approved a new share repurchase program, under which the company is authorized to repurchase up to $30 million of its common stock during fiscal 2016.

Patrick Jermain, Senior Vice President and CFO, commented, "As part of our annual strategy planning process, we evaluate projected free cash flows for the potential of returning cash to shareholders. This repurchase program is reflective of our disciplined approach of returning cash to shareholders and our commitment to maximizing total shareholder return. We believe that repurchasing Plexus stock at current market prices is an attractive use of our capital resources, with the opportunity to create shareholder value."

The authorized repurchases represent approximately 2% of current market capitalization. Plexus does not have a specific schedule or commitment for the repurchase of these shares; however, subject to market factors, it expects to complete the authorized repurchases on a relatively consistent basis over fiscal 2016.



Suggested Items

RTW SMTAI: Steve Greathouse Discusses Award, Highlights Need for New Engineers

10/29/2018 | Real Time with...SMTAI
Steve Greathouse, senior staff engineer at Plexus Corp., and recipient of SMTA’s Excellence in Leadership Award this year, speaks about the magic of the SMTA as a collaborative and supportive professional organization. He also discusses the need for “new blood” to join the manufacturing workforce as more senior engineers leave the industry.

Collaboration between OEM and EMS to Combat Head-on-Pillowing Defects (Part 2)

08/28/2015 | I-Connect007
There have been many publications, industry workshops, and symposia that describe process mitigation techniques for minimizing the occurrence of head-on-pillow defects during surface mount assembly. In this article, the authors address the root cause of the HoP defect—specifically the link between HoP defects and component warpage.

Copyright © 2020 I-Connect007. All rights reserved.